A Phase I/IIa Dose-Escalation Study of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) Subjects
Phase of Trial: Phase I/II
Latest Information Update: 22 Sep 2015
At a glance
- Drugs Decitabine (Primary) ; Genistein
- Indications Non-small cell lung cancer; Solid tumours
- Focus Adverse reactions
- 22 Sep 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.
- 01 Nov 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.